Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Mar 6;43(8):1044–1061. doi: 10.1111/ejn.13208

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2016 The Authors. European Journal of Neuroscience published by Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Retrograde neuronal label in the septal (dorsal) subiculum, postsubiculum (Post) and CA1 in the left hemisphere following tracer injections into (top panel) pars medialis of the medial mammillary nucleus (medial MB), (middle panel) the AM and (bottom panel) the AV. In each case, insets show injection site locations and tracer spread. Injections into the medial mammillary nucleus resulted in most labelled cells in mid‐subiculum regions R2 and R3 (top panel). Subiculum label density was greater proximal to CA1 following AM injections (middle panel), while tracer injections into AV resulted in most retrogradely label distal to CA1 (bottom panel). AD, anterodorsal nucleus; CA1, CA1 hippocampal subfield; CtB‐488, non‐toxic B‐subunit of cholera toxin, Alexa‐Fluor 488 conjugate; IAM, interanteromedial nucleus; LM, lateral MB nucleus; ML, pars lateralis of the medial mammillary nucleus; MM, pars medialis of the medial mammillary nucleus. Scale bars, 500 μm (injection sites), 250 μm (subiculum).